Michael Taitel is currently the director of health outcomes & analytics at Walgreens. He leads a team of analysts responsible for developing outcomes research studies to support Walgreen’s initiatives in the pharmacy, PBM, retail and worksite clinics, and other innovations that provide affordable and convenient access to health and wellness services. He is the author of numerous published articles, a member of the American College of Occupational and Environmental Medicine, the American Psychological Association, and the International Society for Pharmacoeconomics and Outcomes Research. Mike previously served as vice president for the Alere Center for Health Intelligence. He was responsible for research studies on behavior change, health risk assessment, wellness savings, medication adherence and productivity.
Walgreens has emerged as a leader in implementing and evaluating digital health solutions. The pharmacy giant has developed, tested, and disseminated web-, app-, and SMS-based programs focused on improving medication adherence, immunization rates, healthcare costs, behavioral self-management, and health promotion.
In this session, two of the organization’s digital health leaders will present research that demonstrates how technologies including connected and wearable devices are leveraged to improve health and customer loyalty. The discussion will also address, among other things, Walgreens’ partnership with other organizations to integrate apps and devices into its digital ecosystem; and its strategy to enhance current offerings, engage key populations, and expand into telemedicine, tele-pharmacy, and precision medicine.
- A national pharmacy offering digital health innovations can measurably improve health outcomes.
- Innovative health technology organizations of any size can benefit from partnerships that deliver interventions and incent patients to improve health.
- More work is needed for digital health programs to increase engagement of older adults and patients within health disparity populations.